ARQT vs CTSH · rev $235.3M vs P/E 12, rev $21.11B
Arcutis Biotherapeutics Inc (ARQT) versus Cognizant Technology Solutions Corp Class A (CTSH) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.
Latest reported CTSH revenue for 2025-12-31 was $21.11B. Net income was $2.23B. Revenue was up 7.0% from 2024-12-31 to 2025-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
ARQT currently screens at market cap $1.64B. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
Not investment advice. Open the ARQT and CTSH stock pages for the full models.
Not investment advice.